CS Paper Radar

Intervention Granularity Matters: Coherent Treatment Bundles in Counterfactual Simulation with Clinical World Models

Fangzhou Wang, Yixuan Yang, Camilla Balzarotti, Rishikesan Kamaleswaran

cs.LG ·submitted 2026-09-18 15:33 UTC · v1

Abstract

Counterfactual simulation with a clinical world model means fixing a patient's history, changing the treatment, and reading off the predicted response. Doing so requires deciding what counts as one intervention. In clinical settings, interventions are documented as bundles: a co-occurrence audit of 945,707 patient-hours from MIMIC-IV shows groups of components, such as every parameter of a dialysis circuit, that never appear apart, so an edit that changes one component on its own describes an hour that never occurs in the data. We hypothesize that the granularity at which an intervention is edited changes how a world model responds, and test this with Clin-JEPA, a latent world model of patient trajectories conditioned on hourly treatment text. At 1,019 documented onsets of invasive ventilation, we keep the patient's history and other treatments fixed and compare editing one ventilator setting with editing the complete configuration recorded for a real patient with the most similar recent trajectory. The complete bundle moves the predicted next state further than any single setting, consistently across all five settings, and the difference remains after accounting for how much each edit changes the model's input. Intervention granularity therefore materially affects the response of a clinical world model: single-component edits may understate treatment sensitivity, and bundle-aware editing may offer a better-supported basis for counterfactual treatment simulation.

Closest papers

Nearest neighbours by meaning across the whole index.

When to Trust Simulated Patient Responses:Support-Gated World Models for Vasopressor Decision Support

cs.AI ·2026-11-13 ·Yifan Jin, Tao Liu
similarity 0.66
Abstract

Clinical world models expose language-model agents to predicted patient responses, but simulations can be unreliable for poorly supported treatments or unfamiliar hospitals. We introduce Support-Gated World-Model decision support, a lightweight extension of a propose--simulate--refine agent. A recurrent dynamics ensemble predicts short-horizon physiological responses to documented norepinephrine dose categories, while a behavior model estimates observational action support. The interface withholds predictions with insufficient support or excessive ensemble disagreement and abstains when no candidate qualifies. Evaluation on eICU-CRD includes 70 hospitals and 30,700 decision transitions, with 14 hospitals held out for testing. At 62.0% factual-transition coverage, joint gating yields a MAP mean absolute error of 7.3 mmHg, compared with 9.2 mmHg for random selection at the same coverage. The gated agent achieves 60.0% agreement with recorded actions at 81.0% decision coverage, compared with 55.0% agreement and 99.5% coverage for an ungated ensemble agent. Component ablations show lower factual risk with joint gating than with either gate alone.These results characterize a reliability--coverage trade-off in selective clinical simulation; they do not identify individualized treatment effects or establish improved patient outcomes.

0.15

Same Predictions, Different Harms: Causal Auditing of Patient World Models

cs.AI stat.ME ·2026-10-04 ·Yicheng Qi, Xiyi Xiong
similarity 0.61
Abstract · 35 pages, 4 figures. Includes appendices

Patient world models used for clinical trial simulation can agree on transition kernels and arm-specific risks, yet disagree on the fraction of patients harmed by switching treatment---the counterfactual quantity that matters for intervention-aware reasoning. We audit this reliability gap in a two-stage shared-response SCM: a categorical intermediate health state is followed by common terminal care. Under independent stages, the sharp harm interval has closed-form endpoints for at most three intermediate states, with an exactness boundary at four states. Declared dependence and response-mismatch budgets yield calibrated outer bounds when stage independence or complete mediation is relaxed; in a symmetric three-state model the entire sensitivity frontier is sharp, $[0,\min\{1/2,1/3+(ρ+δ)/2\}]$, and shows exactly how budgets erase the gain over endpoint-only bounds. Two eight-variable response LPs propagate interventional uncertainty for finite-sample audits. Exact witnesses verify attainability. On public clinical simulators (EpiCare; sepsis), native configurations show little resolved stage dependence and no additional joint-compatibility gain over pairwise transport---honest negative results for reliability claims. All experiments are locally reproducible; guarantees remain conditional on the stated causal model. The results provide a concrete protocol for deciding when a patient world model is safe to trust for counterfactual harm.

0.36

PatientWM: Towards Generalizable Clinical World Models via Unified Patient States

cs.AI ·2026-10-12 ·Ziwen Kan, Jie Peng, Bo Yan, Davis Hobley, Zheng Zhang +3 more
similarity 0.60
Abstract · 30 pages, 6 figures, 14 tables

Clinical decisions depend on anticipating how a patient's condition will evolve as treatment is adjusted and new evidence becomes available. Existing medical world models capture patient-state evolution, but often define the evolving state around a particular modality or task, limiting reuse as inputs or prediction targets change. These models also retain history through observation sequences or recurrent or latent summaries rather than exposing preceding patient states and clinical actions as an ordered transition context. This distinction matters because similar current measurements may follow different recent changes, treatment exposures, and observed responses. To tackle these limitations, we propose PatientWM, a clinical world-model framework built around a unified patient state and sequential latent history. Availability-aware encoders integrate observations available at each decision time into the patient state, while typed decoders produce task-specific clinical readouts without defining the state around any single target. PatientWM further conditions each next-state prediction on the current state and supplied action together with a bounded, ordered history of preceding latent patient states and clinical actions, preserving recent treatment and response context. Experiments across MIMIC-III, MIMIC-IV, and three external clinical datasets show superior performance in clinical prediction, multi-step forecasting, and action-planning evaluation. Transfer experiments further demonstrate the generalizability of PatientWM's patient state. Together, these results establish its ability to forecast clinical evolution and support planning.

0.09

Disparity Laundering: Consensus Without Fairness in Clinical Multi-Agent Systems

cs.AI cs.MA ·2026-10-28 ·Xiaoyang Wang, Tianrui Wang, Christopher C. Yang
publishedcode/data similarity 0.60
Abstract · 21 pages, 8 figures. Code: https://github.com/wangxiaoyang0412/disparity-laundering . Committed to EACL 2027

Clinical large language models are increasingly fielded as multi-agent teams, on the assumption that deliberation averages out individual error. It does not average out bias. Across a full factorial of five model families and four aggregation topologies on 120 real MIMIC-IV emergency cases under counterfactual demographic swaps, no configuration neutralizes the disparity: all 20 cells commit the direction of their agents' independent answers, giving Black patients more acute triage. Every model has a topology that amplifies its baseline gap, but which one varies by model, so no design is reliably safe or reliably amplifying: the disparity is relocated, never removed. Late-stage fixes fail: fairness instructions and demographic masking leave the gap untouched, and per-agent self-debiasing widens it, because the bias is already encoded in the agents' ordinary clinical numbers. We call this disparity laundering; the audits now applied to clinical AI, per model, per output, per version, can certify the parts but never the committed decision. Interventions close the gap exactly when they make counterfactual versions visible inside the system and pool them, through deliberation, into the committed decision. A diverse-perspective ensemble does both while keeping the team, with no retraining or architectural change: the disparity falls by 67 to 94% where all five perspectives pool at every round, and the one topology that never pools them is the one it cannot reliably repair. Medical multi-agent systems do not filter demographic bias; they launder it into plausible decisions no single-version audit can catch, and the only defense is to make the bias visible.

0.41

Sign-Constrained Intervention Effects for Domain-Generalizable ICU World Models

cs.CE ·2026-10-08 ·Zhen Xu, Nicholas Konz, Zhen Tan, Zachary Plotkin, Tianlong Chen
similarity 0.59
Abstract · 24 pages, 6 figures, 15 tables

Predicting how a patient's vital signs respond to an intervention is a central question in intensive care. World models can do so by learning dynamics as a function of prior actions. However, such models tend to be brittle outside of training data. Clinicians choose drug dosages based on the patient's state, so the association a model learns between dose and outcome runs opposite to the drug's effect, generalizing poorly to out-of-distribution (OOD) dosing practices. Yet, pharmacological information provides the directional effects of different drugs, which are invariant to OOD shifts. To resolve the OOD sensitivity of current ICU world models, we introduce PHYSIO WORLD, which isolates an intervention's effect by evaluating a forward pass twice: once under recorded doses, and once with those doses set to zero. The difference is projected onto pharmacologically admissible effect directions stated by 70 rules over 28 drugs, leaving the magnitude to be learned from data. Across five distribution-shift parameters over cohorts from three intensive-care databases, and against forecasters, counterfactual models, and invariance objectives, PHYSIO WORLD attains the lowest OOD RMSE in every setting, improving on the strongest external baseline by 8-12%, while matching the in-distribution error of its backbone. Reversing the pharmacological directions degrades accuracy below the backbone, and data-mined directions recover almost no gain, indicating the improvement derives from the content of the pharmacological knowledge. The construction may extend to other settings where the sign of an effect is known in advance and its magnitude is confounded by treatment assignment.

0.17

Learning response-aware patient dynamics for respiratory support

cs.AI ·2026-09-26 ·Xiaolei Lu, Shamim Nemati
similarity 0.59
Abstract · Under review

Respiratory support can shape the short-term physiological trajectory of critically ill patients, but patients receiving the same intervention may follow different physiological trajectories. Clinical patient dynamics models typically predict future states from recent physiology and recorded interventions, while physiological change is mainly represented through the predicted future state. We propose a response-aware patient dynamics model that explicitly represents physiological change during autoregressive state updating. The model decomposes predicted physiological change into state-dependent baseline dynamics and respiratory-support-associated deviations, with room air providing a reference for the decomposition. We provide a formal analysis of this reference-anchored formulation. A response pathway encodes the predicted physiological change and uses it to update the latent patient state across the forecast horizon. Across ICU cohorts from two independent institutions, the proposed model achieves comparable overall trajectory prediction to patient dynamics baselines, with more consistent improvements when physiological states are changing.

0.08

Intervention-Aware Clinical World Model for Post-Op Outcome Forecasting in Cardiology

cs.LG cs.CV ·2026-08-13 ·Yunsung Chung, Yingshuo Liu, Abboud F. Hassan, Han Feng, Mary M. Maleckar +2 more
published similarity 0.59
Abstract · Medical World Models (MWM) Workshop at MICCAI 2026

Many clinical prediction models treat post-intervention outcomes as a one-step mapping from baseline measurements to a future endpoint. However, recovery after a procedure often unfolds as an irregular trajectory: clinical observations, medication changes, repeat interventions, and physiological measurements are recorded asynchronously and can change risk assessment over time. We propose an intervention-aware clinical world model that represents each patient with a structured latent state and evolves it through time-ordered post-intervention events. The model first encodes baseline imaging into a 3D spatial latent state. It then updates this state using procedural context, static covariates, elapsed time, and peri-event physiological embeddings. Follow-up imaging provides training-only supervision through a latent forecasting objective. We apply the framework to atrial fibrillation ablation. During the 90-day recovery window, irregular post-procedure records provide clinically meaningful evidence for long-term recurrence risk. In repeated internal cross-validation on DECAAF-II, our model achieves AUROC 0.756 and AUPRC 0.777 for recurrence prediction. It also achieves a scar-extent MAE of 2.971 percentage points without requiring follow-up MRI intensities at inference. The learned state supports recurrence-risk queries at different horizons and retrospective input editing of blanking-period records.

0.46

Does Your Trial Simulator Know What the Drug Does? An Intervention-Blind Test of Interventional Validity on 7,207 Registered Trials

cs.AI stat.APcs.LG ·2026-11-04 ·Alicem Koyun
publishedbenchmarktheorycode/data similarity 0.58
Abstract · Oral presentation at the NeurIPS 2026 Workshop on World Models for High-Stakes Health. 31 pages, 5 figures. Code and data: https://github.co…

Patient world models are increasingly proposed as simulators of clinical trials, and recent surveys rank their capabilities on a ladder from temporal prediction to counterfactual rollouts. Position on that ladder is currently assigned by reading papers rather than by measurement. We turn the counterfactual rung into a measured quantity. From 30,119 completed phase 2/3 trials with results posted to ClinicalTrials.gov we construct 9,996 audited within-trial contrasts from 7,207 trials, and we score a simulator on how much of its accuracy depends on knowing which intervention was tested. The instrument is an intervention-blind reference: the same model, trained on the same trials, with every intervention-identifying field withheld. Interventional skill is the error the full model removes relative to that reference. On a temporal split (878 test contrasts from 655 trials) a registry-trained gradient-boosting simulator removes a fifth of the error of a trivial baseline, but its interventional skill is -0.12 (95% CI -0.21 to -0.05): withholding the intervention makes it better, and no alternative featurisation, stratum, temporal cut or same-molecule retrieval yields an interval above zero. A frontier language model reading only the registered protocol has interventional skill 0.20 [0.08, 0.31]; smaller and open-weight models sit at the limit of detection. Perturbation tests show the large model uses the intervention as such: swapping the arms reverses the sign of its prediction in 86% of contrasts. The blind reference is itself not drug-blind (a language model recovers the withheld drug class 45% of the time from the blind prompt), so interventional skill is a conservative lower bound. A reliability layer shows that ranking by predicted error lowers it but that calibrated error control does not transfer under temporal shift. Benchmark, code, prompts and per-call model outputs are released.

0.53